BACKGROUND: Research on the structure of co-morbidity among common mental disorders has largely focused on current prevalence rather than on the development of co-morbidity. This report presents preliminary results of the latter type of analysis based on the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). METHOD: A national survey was carried out of adolescent mental disorders. DSM-IV diagnoses were based on the Composite International Diagnostic Interview (CIDI) administered to adolescents and questionnaires self-administered to parents. Factor analysis examined co-morbidity among 15 lifetime DSM-IV disorders. Discrete-time survival analysis was used to predict first onset of each disorder from information about prior history of the other 14 disorders. RESULTS: Factor analysis found four factors representing fear, distress, behavior and substance disorders. Associations of temporally primary disorders with the subsequent onset of other disorders, dated using retrospective age-of-onset (AOO) reports, were almost entirely positive. Within-class associations (e.g. distress disorders predicting subsequent onset of other distress disorders) were more consistently significant (63.2%) than between-class associations (33.0%). Strength of associations decreased as co-morbidity among disorders increased. The percentage of lifetime disorders explained (in a predictive rather than a causal sense) by temporally prior disorders was in the range 3.7-6.9% for earliest-onset disorders [specific phobia and attention deficit hyperactivity disorder (ADHD)] and much higher (23.1-64.3%) for later-onset disorders. Fear disorders were the strongest predictors of most other subsequent disorders. CONCLUSIONS: Adolescent mental disorders are highly co-morbid. The strong associations of temporally primary fear disorders with many other later-onset disorders suggest that fear disorders might be promising targets for early interventions.
BACKGROUND: Research on the structure of co-morbidity among common mental disorders has largely focused on current prevalence rather than on the development of co-morbidity. This report presents preliminary results of the latter type of analysis based on the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). METHOD: A national survey was carried out of adolescent mental disorders. DSM-IV diagnoses were based on the Composite International Diagnostic Interview (CIDI) administered to adolescents and questionnaires self-administered to parents. Factor analysis examined co-morbidity among 15 lifetime DSM-IV disorders. Discrete-time survival analysis was used to predict first onset of each disorder from information about prior history of the other 14 disorders. RESULTS: Factor analysis found four factors representing fear, distress, behavior and substance disorders. Associations of temporally primary disorders with the subsequent onset of other disorders, dated using retrospective age-of-onset (AOO) reports, were almost entirely positive. Within-class associations (e.g. distress disorders predicting subsequent onset of other distress disorders) were more consistently significant (63.2%) than between-class associations (33.0%). Strength of associations decreased as co-morbidity among disorders increased. The percentage of lifetime disorders explained (in a predictive rather than a causal sense) by temporally prior disorders was in the range 3.7-6.9% for earliest-onset disorders [specific phobia and attention deficit hyperactivity disorder (ADHD)] and much higher (23.1-64.3%) for later-onset disorders. Fear disorders were the strongest predictors of most other subsequent disorders. CONCLUSIONS:Adolescent mental disorders are highly co-morbid. The strong associations of temporally primary fear disorders with many other later-onset disorders suggest that fear disorders might be promising targets for early interventions.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Mackenzie S Mills; Christine M Embury; Alicia K Klanecky; Maya M Khanna; Vince D Calhoun; Julia M Stephen; Yu-Ping Wang; Tony W Wilson; Amy S Badura-Brack Journal: J Child Adolesc Trauma Date: 2019-08-19
Authors: Yoichiro Takayanagi; Adam P Spira; Kimberly B Roth; Joseph J Gallo; William W Eaton; Ramin Mojtabai Journal: JAMA Psychiatry Date: 2014-03 Impact factor: 21.596
Authors: Nicholas Peiper; Richard Clayton; Richard Wilson; Robert Illback; Elizabeth O'Brien; Richard Kerber; Richard Baumgartner; Carlton Hornung Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2015-02-05 Impact factor: 4.328
Authors: Timothy L Neal; Alex B Diamond; Scott Goldman; Karl D Liedtka; Kembra Mathis; Eric D Morse; Margot Putukian; Eric Quandt; Stacey J Ritter; John P Sullivan; Victor Welzant Journal: J Athl Train Date: 2015-03-02 Impact factor: 2.860
Authors: Jae-Won Kim; Haifeng Yu; Neal D Ryan; David A Axelson; Benjamin I Goldstein; Tina R Goldstein; Rasim S Diler; Kelly Monk; Mary Beth Hickey; Dara J Sakolsky; John A Merranko; Boris Birmaher Journal: J Clin Psychiatry Date: 2015-05 Impact factor: 4.384
Authors: Oleguer Plana-Ripoll; Carsten Bøcker Pedersen; Yan Holtz; Michael E Benros; Søren Dalsgaard; Peter de Jonge; Chun Chieh Fan; Louisa Degenhardt; Andrea Ganna; Aja Neergaard Greve; Jane Gunn; Kim Moesgaard Iburg; Lars Vedel Kessing; Brian K Lee; Carmen C W Lim; Ole Mors; Merete Nordentoft; Anders Prior; Annelieke M Roest; Sukanta Saha; Andrew Schork; James G Scott; Kate M Scott; Terry Stedman; Holger J Sørensen; Thomas Werge; Harvey A Whiteford; Thomas Munk Laursen; Esben Agerbo; Ronald C Kessler; Preben Bo Mortensen; John J McGrath Journal: JAMA Psychiatry Date: 2019-03-01 Impact factor: 21.596
Authors: Carlos Blanco; María García-Anaya; Melanie Wall; José Carlos Pérez de Los Cobos; Ewelina Swierad; Shuai Wang; Nancy M Petry Journal: Drug Alcohol Depend Date: 2015-02-25 Impact factor: 4.492
Authors: Chelsea Sawyers; Thomas Ollendick; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft; Dever M Carney; Roxann Roberson-Nay; John M Hettema Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2019-02-01 Impact factor: 3.568